Electric shock-like sensations in 42 cancer patients: Clinical characteristics and distinct etiologies

Journal of Neuro-Oncology

Volumn 29, Issue 2, 1996, Pages 175-181

  Lossos, Alexander ^a   Siegal, Tali ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cisplatin polyneuropathy; Lhermitte's sign; Radiation myelopathy

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTRIC SHOCK; FEMALE; HUMAN; MALE; NEUROLOGY; POLYNEUROPATHY; RADIATION INJURY; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SPINAL CORD DISEASE; THIAMINE DEFICIENCY;

EID: 0030015577     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00182141     Document Type: Article

References (26)

1. Haerer AF: DeJong's The neurological examination. 5th ed. JB Lippincot, Philadelphia, 1992
2. Vollmer L, Brass LM, Waxman SG: Lhermitte's sign in a patient with herpes zoster. J Neurol Sci 106: 153-157, 1991
3. Jones A: Transient radiation myelopathy (with reference to Lhermitte's sign of electrical paraesthesia). Brit J Radiol 37: 727-744, 1964
4. Siegal T, Haim N: Cisplatin peripheral neuropathy: common manifestations of demyelinating syndromes, muscle cramps and off-therapy deterioration. Cancer 66: 1117-1120, 1990
5. Wen Y, Blancherd KL, Block CC, Loeffler JS, Davis DG, Lacroix LA, Antin JH: Development of Lhermitte's sign after bone marrow transplantation. Cancer 69: 2262-2266, 1992
6. Ventafridda V, Caraceni A, Martini C, Sbanotto A, De Conno F: On the significance of Lhermitte's sign in oncology. J Neuro-Oncol 10: 133-137, 1991
7. Word JA, Kalokhe UP, Aaron BS, Elson HR: Transient radiation myelopathy in patients with Hodgkin's disease treated by mantle irradiation. Int J Radiat Oncol Biol Phys 6: 1731-1733, 1980
8. Dewar J, Lunt H, Abernethy DA, Dady P, Haas LF: Cisplatin neuropathy with Lhermitte's sign. J Neurol Neurosurg Psychiat 49: 96-99, 1986
9. Walther PL, Rossitch EJr, Bullard DS: The development of Lhermitte's sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination. Cancer 60: 2170-2172, 1987
10. Eeles R, Tait DM, Peckham MJ: Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer. Cancer Treat Rep 70: 905-907, 1986
11. Carmel RJ, Kaplan HS: Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication and complications. Cancer 37: 2813-2825, 1976
12. Hutchinson GB: Survival and complications of radiotherapy following involved and extended field therapy of Hodgkin's disease, stages I and II. A collaborative study. Cancer 38: 288-305, 1976
13. Fein DA, Marcus RB Jr, Parsons JT, Mendenhall WM, Million RR: Lhermitte's sign: incidence and treatment variables influencing risk after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 27: 1029-1033, 1993
14. Nordin M, Nystrom B, Wallin U, Hagbarth K-E: Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain 20: 231-245, 1984
15. Smith KJ, McDonald WI: Spontaneous and evoked electrical discharges from a central demyelinating lesion. J Neurol Sci 55: 39-48, 1982
16. Howe JF, Loeser JD, Calvin WH: Mechanosensitivity of dorsal root ganglia and chronically injured axons: a physiological basis for the radicular pain of nerve root compression. Pain 3: 25-41, 1977
17. Dorfman LJ, Donaldson SS, Gupta PR, Bosley TM: Electrophysiologic evidence of subclinical injury to the posterior columns of the human spinal cord after therapeutic radiation. Cancer 50: 2815-2819, 1982
18. Gregg RW, Molepo JM, Monpetit VJA, Mikael NZ, Redmond D, Gadia M, Stewart DJ: Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10: 795-803, 1992
19. Clark AW, Parhad IM, Griffin JW, Price DL: Neurotoxicity of cis-platinum: pathology of the central and peripheral nervous systems. Neurol 30: 429, 1980
20. Walsh TJ, Clark AW, Parhad IM, Green WR: Neurotoxic effects of cisplatin therapy. Arch Neurol 39: 719-720, 1982
21. Hansen SW, Helweg-Larsen S, Trojaborg W: Long-term neurotoxicity in patients treated with cisplatin, vinblastin, and bleomycin for metastatic germ cell cancer. J Clin Oncol 7: 1457-1461, 1989
22. Daugaard GK, Petrera J, Trojaborg W: Electrophysiological study of the peripheral and central neurotoxic effect of cisplatin. Acta Neurol Scand 76: 86-93, 1987
23. Ongerboer de Visser BW, Tiessens G: Polyneuropathy induced by cisplatin. In: Rose FC, Fields WS (eds) Prog Exp Tumor Res. Karger, Basel, 29: 190-196, 1985
24. Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE, Peters LJ: The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 25: 459-464, 1993
25. Schultheiss TE, Stephens LC: Permanent radiation myelopathy. Br J Radiol 65: 737-753, 1992
26. Wang PU, Shen WC, Jan JS: MRI imaging in radiation myelopathy. AJNR 13: 1049-1055, 1992